Key statistics
On Tuesday, Trevi Therapeutics Inc (TRVI:NMQ) closed at 3.15, -21.25% below its 52-week high of 4.00, set on Mar 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.93 |
---|---|
High | 3.18 |
Low | 2.83 |
Bid | 3.05 |
Offer | 3.28 |
Previous close | 2.88 |
Average volume | 472.14k |
---|---|
Shares outstanding | 72.59m |
Free float | 71.69m |
P/E (TTM) | -- |
Market cap | 209.06m USD |
EPS (TTM) | -0.3879 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Press releases
- Trevi Therapeutics Provides Update on Haduvio's Clinical Development Program
- Trevi Therapeutics Announces Appointment of James V. Cassella, Ph.D., as Chief Development Officer
- Trevi Therapeutics Announces Additional Analyses of Cough Relief Time from Ph2a CANAL Trial Accepted for Oral Presentation at CHEST 2024
- Trevi Therapeutics to Participate in September Investor and Medical Conferences
- Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance
- Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024
More ▼